A newly acquired Novartis drug cut signs of inflammation. The test will be whether that can improve people's heart health.
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. When Baby KJ was introduced to the world ...
RFK Jr.'s vaccine questions in Samoa, former Stanford president rebuts fraud allegations, and more health news from Morning ...
Juul has received FDA clearance to sell an updated version of its e-cigarette, which includes an optional age-verification ...
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news ...
AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a ...
AstraZeneca detailed the surprise failure of a closely watched heart disease clinical trial, laying out how its experimental ...
WASHINGTON — After Pennsylvania health authorities announced that two unvaccinated people had died from measles-associated ...
WASHINGTON — Sen. Bill Cassidy (R-La.) released a report on Thursday criticizing the Food and Drug Administration for not ...
The FDA approved a life-extending treatment for advanced pancreatic cancer from Revolution Medicines that is the first to ...
Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study ...
Opposition to abortion restrictions should focus on values, not statistics, writes David N. Hackney, author of “Impossible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results